Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Apr 1;181(4):460-462.
doi: 10.1001/jamainternmed.2020.7986.

Antibodies, Immunity, and COVID-19

Brad Spellberg  1 , Travis B Nielsen  2 , Arturo Casadevall  3
Affiliations
Comment

Antibodies, Immunity, and COVID-19

Brad Spellberg et al. JAMA Intern Med. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Spellberg reported personal fees from IQVIA and service on multiple data safety monitoring boards for therapeutics for COVID-19, with no financial interest in the sponsors, products, or outcomes of the trials during the conduct of the study No other disclosures were reported.

Comment on

  • Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.
    Bajema KL, Wiegand RE, Cuffe K, Patel SV, Iachan R, Lim T, Lee A, Moyse D, Havers FP, Harding L, Fry AM, Hall AJ, Martin K, Biel M, Deng Y, Meyer WA 3rd, Mathur M, Kyle T, Gundlapalli AV, Thornburg NJ, Petersen LR, Edens C. Bajema KL, et al. JAMA Intern Med. 2021 Apr 1;181(4):450-460. doi: 10.1001/jamainternmed.2020.7976. JAMA Intern Med. 2021. PMID: 33231628 Free PMC article.

References

    1. Percivalle E, Cambiè G, Cassaniti I, et al.Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020. Euro Surveill. 2020;25(24):2001031. - PMC - PubMed
    1. Pollán M, Pérez-Gómez B, Pastor-Barriuso R, et al.; ENE-COVID Study Group. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study. Lancet. 2020;396(10250):535–544. - PMC - PubMed
    1. Havers FP, Reed C, Lim T, et al.Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020. JAMA intern Med. 2020. Published online July21, 2020. doi:10.1001/jamainternmed.2020.4130 - DOI - PubMed
    1. Bajema KL, Wiegand RE, Cuffe K, et al.Estimated SARS-CoV-2 seroprevalence in the United States as of September 2020. JAMA intern Med. Published online November 24, 2020. doi:10.1001/jamainternmed.2020.7976 - DOI - PMC - PubMed
    1. Fontanet A, Cauchemez S. COVID-19 herd immunity: where are we? Nat Rev Immunol. 2020; 20(10):583–584. - PMC - PubMed

Substances